trending Market Intelligence /marketintelligence/en/news-insights/trending/FNjV_G_RQIri5Eag1EOsbQ2 content esgSubNav
In This List

XTL Biopharmaceuticals CFO to step down

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


XTL Biopharmaceuticals CFO to step down

David Kestenbaum plans to cease his services as CFO of XTL Biopharmaceuticals Ltd. and pursue other opportunities.

Kestenbaum will continue working during his notice period, and his successor will be announced in due course.